Human CD2 / SRBC Protein, His Tag (MALS verified)
分子別名(Synonym)
CD2,SRBC,LFA-2,T11
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human CD2, His Tag (CD2-H5226) is expressed from human 293 cells (HEK293). It contains AA Lys 25 - Asp 209 (Accession # AAH33583).
Predicted N-terminus: Lys 25
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 22.3 kDa. The protein migrates as 33-40 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
T細(xì)胞表面抗原CD2也稱為紅細(xì)胞受體、LFA-2、LFA-3受體、Rosette受體、T細(xì)胞表面抗體T11/Leu-5和SRBC,是一種存在于T細(xì)胞和自然殺傷(NK)細(xì)胞表面的單程I型膜蛋白。CD2是免疫球蛋白超家族的成員。CD2/SRBC包含1個(gè)Ig-like C2型(免疫球蛋白樣)結(jié)構(gòu)域和1個(gè)Ig-like V型(免疫蛋白樣)功能域。CD2/SRBC與其他粘附分子相互作用,如人類淋巴細(xì)胞功能相關(guān)抗原-3(LFA-3/CD58)或嚙齒動(dòng)物的CD48,這些分子在其他細(xì)胞表面表達(dá)。除了其粘附特性外,CD2還充當(dāng)T細(xì)胞和NK細(xì)胞的共刺激分子。CD2是T細(xì)胞和NK細(xì)胞的特異性標(biāo)記,因此可用于免疫組織化學(xué)以鑒定組織切片中此類細(xì)胞的存在。
關(guān)鍵字: CD2;CD2蛋白;SRBC蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。